Citadel Advisors’s Champions Oncology CSBR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-22,902
| Closed | -$199K | – | 5996 |
|
|
2025
Q1 | $199K | Buy |
22,902
+12,034
| +111% | +$104K | ﹤0.01% | 4882 |
|
|
2024
Q4 | $93.1K | Buy |
+10,868
| New | +$93.1K | ﹤0.01% | 5228 |
|
|
2024
Q3 | – | Sell |
-10,218
| Closed | -$52.8K | – | 5916 |
|
|
2024
Q2 | $52.8K | Sell |
10,218
-2,607
| -20% | -$13.5K | ﹤0.01% | 5162 |
|
|
2024
Q1 | $62.8K | Sell |
12,825
-1,802
| -12% | -$8.83K | ﹤0.01% | 5252 |
|
|
2023
Q4 | $79.1K | Buy |
14,627
+3,695
| +34% | +$20K | ﹤0.01% | 4956 |
|
|
2023
Q3 | $68K | Sell |
10,932
-4,483
| -29% | -$27.9K | ﹤0.01% | 4974 |
|
|
2023
Q2 | $97K | Buy |
15,415
+2,931
| +23% | +$18.4K | ﹤0.01% | 4771 |
|
|
2023
Q1 | $50.2K | Sell |
12,484
-25,533
| -67% | -$103K | ﹤0.01% | 5155 |
|
|
2022
Q4 | $171K | Buy |
38,017
+704
| +2% | +$3.18K | ﹤0.01% | 4779 |
|
|
2022
Q3 | $280K | Buy |
37,313
+20,716
| +125% | +$155K | ﹤0.01% | 4601 |
|
|
2022
Q2 | $134K | Buy |
16,597
+518
| +3% | +$4.18K | ﹤0.01% | 5168 |
|
|
2022
Q1 | $131K | Buy |
+16,079
| New | +$131K | ﹤0.01% | 5517 |
|
|
2016
Q4 | – | Sell |
-11,929
| Closed | -$20K | – | 3643 |
|
|
2016
Q3 | $20K | Buy |
+11,929
| New | +$20K | ﹤0.01% | 3417 |
|